Company profile: CoreRx
1.1 - Company Overview
Company description
- Provider of contract pharmaceutical drug product development services to pharma and biotech, delivering cGMP solutions for dosage form development. Offerings include preformulation, formulation, analytical and stability services, GMP manufacturing and packaging, modified-release dosage forms, and oral solids (tablets and capsules) including immediate and controlled release.
Products and services
- Manufacturing and Packaging: cGMP-compliant operations that produce and package diverse pharmaceutical dosage forms, scaling from clinical batches to commercial runs with rigorous quality systems and timely, clearly communicated results
- Formulation: Custom-engineered development of drug formulations across all phases—from preclinical research through commercial processes—architecting pharmaceutical dosage forms that advance products into the clinic faster under cGMP oversight
- Analytical and Stability: Laboratory-grade testing services supporting pre-formulation, formulation, and manufacturing, employing state-of-the-art instruments and rigorous quality systems to generate timely, clearly communicated stability and analytical results
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to CoreRx
Biopta
HQ: United Kingdom
Website
- Description: Provider of human tissue-based contract research services for drug development, using ethically donated fresh human tissues from surgery to predict drug behavior and bridge animal studies and clinical trials. Services include fresh human tissue pharmacology, a digital human tissue assay catalog, Alvetex 3D tissue models, REPROSKIN full-thickness skin, neurite outgrowth models, and clinical lab services with AI-driven biospecimen analysis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Biopta company profile →
BioMedion
HQ: Germany
Website
- Description: Provider of compliance management software and services for the highly regulated life science industry, medicines agencies, and national competent authorities. Offers GxP quality, compliance, and archiving solutions, including neuronOS, IMAGE+, WATCH+, regulatory operations services, raw data archiving, and subject-matter expertise, computer system validation, and training management.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioMedion company profile →
Jennewein Biotech
HQ: Germany
Website
- Description: Provider of industrial biotechnology solutions specializing in developing processes for the identification, characterization, and production of scarce, functional monosaccharides and oligosaccharides, with a focus on sugar molecules offering attractive health benefits.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Jennewein Biotech company profile →
Caidya
HQ: United States
Website
- Description: Provider of clinical research services with personalized solutions across therapeutic areas, supported by a proprietary technology platform that integrates data from different systems to create a near real-time view of clinical trials.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Caidya company profile →
Equalis
HQ: Sweden
Website
- Description: Provider of external quality assessment services for medical and diagnostic laboratories.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Equalis company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for CoreRx
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to CoreRx
2.2 - Growth funds investing in similar companies to CoreRx
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for CoreRx
4.2 - Public trading comparable groups for CoreRx
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →